▶ 調査レポート

炎症性疾患治療の世界市場2017

• 英文タイトル:Global Inflammatory Diseases Therapeutics Market Size, Status and Forecast 2022

QYResearchが調査・発行した産業分析レポートです。炎症性疾患治療の世界市場2017 / Global Inflammatory Diseases Therapeutics Market Size, Status and Forecast 2022 / A04108305資料のイメージです。• レポートコード:A04108305
• 出版社/出版日:QYResearch / 2017年3月7日
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:産業未分類
• 販売価格(消費税別)
  Single User¥346,500 (USD3,300)▷ お問い合わせ
  Enterprise¥693,000 (USD6,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、炎症性疾患治療の世界市場について調査・分析し、炎症性疾患治療のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、炎症性疾患治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:炎症性疾患治療の販売量、Revenue:炎症性疾患治療の売上高)

・炎症性疾患治療市場概要
・炎症性疾患治療のメーカー別販売量・メーカー別シェア
・炎症性疾患治療の世界市場:種類別販売量・市場シェア
・炎症性疾患治療の世界市場:用途別販売量・市場シェア
・炎症性疾患治療の世界市場:地域別販売量・市場シェア
・炎症性疾患治療のアメリカ市場規模
・炎症性疾患治療の中国市場規模
・炎症性疾患治療のヨーロッパ市場規模
・炎症性疾患治療の日本市場規模
・炎症性疾患治療の東南アジア市場規模
・炎症性疾患治療のインド市場規模
・炎症性疾患治療のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・炎症性疾患治療のコスト分析・価格動向
・炎症性疾患治療の産業チェーン(サプライチェーン分析)
・炎症性疾患治療のマーケティング戦略・販売チャネル、流通業者
・炎症性疾患治療市場への影響要因分析
・炎症性疾患治療の世界市場予測
・炎症性疾患治療のアメリカ市場予測
・炎症性疾患治療の中国市場予測
・炎症性疾患治療のヨーロッパ市場予測
・炎症性疾患治療の日本市場予測
・炎症性疾患治療の東南アジア市場予測
・炎症性疾患治療のインド市場予測
・炎症性疾患治療の種類別世界市場予測
・炎症性疾患治療の用途別世界市場予測
...

This report studies the global Inflammatory Diseases Therapeutics market, analyzes and researches the Inflammatory Diseases Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AstraZeneca
Merck & Co
GlaxoSmithKline
Bristol-Myers Squibb
F-Hoffmann-La-Roche
Eli Lilly and Sanofi
Enlivex Therapeutics Ltd
Gilead Sciences
Immune Pharmaceuticals
Merck
Mitsubishi Tanabe Pharma Corporation
Neovacs
Prometheus Laboratories
Sandoz
Takeda Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Inflammatory Diseases Therapeutics can be split into
Anti-Inflammatory Biologics
Non-Steroidal Anti-Inflammatory Drugs
Corticosteroids
Other

Market segment by Application, Inflammatory Diseases Therapeutics can be split into
Hospitals
Clinics
Other

レポート目次

Table of Contents

Global Inflammatory Diseases Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Inflammatory Diseases Therapeutics
1.1 Inflammatory Diseases Therapeutics Market Overview
1.1.1 Inflammatory Diseases Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Inflammatory Diseases Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Inflammatory Diseases Therapeutics Market by Type
1.3.1 Anti-Inflammatory Biologics
1.3.2 Non-Steroidal Anti-Inflammatory Drugs
1.3.3 Corticosteroids
1.3.4 Other
1.4 Inflammatory Diseases Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other

2 Global Inflammatory Diseases Therapeutics Competition Analysis by Players
2.1 Inflammatory Diseases Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Merck & Co
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Bristol-Myers Squibb
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 F-Hoffmann-La-Roche
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Eli Lilly and Sanofi
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Enlivex Therapeutics Ltd
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Gilead Sciences
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Immune Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Merck
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Inflammatory Diseases Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Mitsubishi Tanabe Pharma Corporation
3.12 Neovacs
3.13 Prometheus Laboratories
3.14 Sandoz
3.15 Takeda Pharmaceuticals

4 Global Inflammatory Diseases Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Inflammatory Diseases Therapeutics Market Size by Type (2012-2017)
4.2 Global Inflammatory Diseases Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Inflammatory Diseases Therapeutics in Future
4.4 Top Consumer/End Users of Inflammatory Diseases Therapeutics

5 United States Inflammatory Diseases Therapeutics Development Status and Outlook
5.1 United States Inflammatory Diseases Therapeutics Market Size (2012-2017)
5.2 United States Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Inflammatory Diseases Therapeutics Development Status and Outlook
6.1 EU Inflammatory Diseases Therapeutics Market Size (2012-2017)
6.2 EU Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Inflammatory Diseases Therapeutics Development Status and Outlook
7.1 Japan Inflammatory Diseases Therapeutics Market Size (2012-2017)
7.2 Japan Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Inflammatory Diseases Therapeutics Development Status and Outlook
8.1 China Inflammatory Diseases Therapeutics Market Size (2012-2017)
8.2 China Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Inflammatory Diseases Therapeutics Development Status and Outlook
9.1 India Inflammatory Diseases Therapeutics Market Size (2012-2017)
9.2 India Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Inflammatory Diseases Therapeutics Development Status and Outlook
10.1 Southeast Asia Inflammatory Diseases Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Inflammatory Diseases Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Inflammatory Diseases Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Inflammatory Diseases Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Inflammatory Diseases Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Inflammatory Diseases Therapeutics Market Size by Application (2017-2022)

12 Inflammatory Diseases Therapeutics Market Dynamics
12.1 Inflammatory Diseases Therapeutics Market Opportunities
12.2 Inflammatory Diseases Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Inflammatory Diseases Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Inflammatory Diseases Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Inflammatory Diseases Therapeutics Product Scope
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) (2012-2017)
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Inflammatory Diseases Therapeutics Market Share by Regions in 2016
Figure United States Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Inflammatory Diseases Therapeutics Market Share by Type in 2016
Figure Anti-Inflammatory Biologics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Non-Steroidal Anti-Inflammatory Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Inflammatory Diseases Therapeutics Market Share by Application in 2016
Figure Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Figure Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Figure Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Merck & Co Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Merck & Co (2012-2017)
Figure Merck & Co Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table F-Hoffmann-La-Roche Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of F-Hoffmann-La-Roche (2012-2017)
Figure F-Hoffmann-La-Roche Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Eli Lilly and Sanofi Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Eli Lilly and Sanofi (2012-2017)
Figure Eli Lilly and Sanofi Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Enlivex Therapeutics Ltd Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Enlivex Therapeutics Ltd (2012-2017)
Figure Enlivex Therapeutics Ltd Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Gilead Sciences Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Gilead Sciences (2012-2017)
Figure Gilead Sciences Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Immune Pharmaceuticals Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Immune Pharmaceuticals (2012-2017)
Figure Immune Pharmaceuticals Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Mitsubishi Tanabe Pharma Corporation Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Mitsubishi Tanabe Pharma Corporation (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Neovacs Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Neovacs (2012-2017)
Figure Neovacs Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Prometheus Laboratories Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Prometheus Laboratories (2012-2017)
Figure Prometheus Laboratories Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Sandoz Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Sandoz (2012-2017)
Figure Sandoz Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Inflammatory Diseases Therapeutics Business Revenue (Million USD) of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Inflammatory Diseases Therapeutics Business Revenue Market Share in 2016
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2012
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2013
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2014
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2015
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2016
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2017
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Inflammatory Diseases Therapeutics
Figure United States Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure United States Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure EU Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure EU Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure Japan Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure Japan Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure China Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure China Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure India Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure India Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Inflammatory Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Inflammatory Diseases Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Inflammatory Diseases Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Inflammatory Diseases Therapeutics Market Size Share by Players in 2017
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Regions in 2017
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Regions in 2022
Figure United States Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Inflammatory Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2017
Figure Global Inflammatory Diseases Therapeutics Market Size Share by Type in 2022
Table Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Inflammatory Diseases Therapeutics Market Size (Million USD) by Application in 2022